Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK256066 in mild to moderate COPD
NCT00549679Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of GSK256066 in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Oct 2007; status: completed.
02
Drugs
GSK256066
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00549679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549679.